| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Departments of 1 Epidemiology, 2 Head and Neck Surgery, 3 Pathology, and 4 Thoracic and Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
ABSTRACT
Purpose: Abnormalities in p27 may alter cell cycle delay required for DNA repair after exposure to carcinogens. A coding exon 1 polymorphism at codon 109 (T
G) in p27 was identified and thought to have an effect on the functions of its protein. We hypothesized that this p27 T109G polymorphism is associated with squamous cell carcinoma of the head and neck (SCCHN) risk.
Experimental Design: We tested this hypothesis in a hospital-based case-control study of 713 patients newly diagnosed with SCCHN and 1224 cancer-free controls frequency matched to the cases by age (±5 years), sex, and smoking status. All subjects were non-Hispanic whites. We genotyped for this p27 variant using genomic DNA from each subject.
Results: Compared with the p27 109VV variant, the p27 109GG variant was associated with a nonsignificantly increased risk of SCCHN [crude odds ratio (OR) = 1.29; 95% confidence interval (CI) = 0.88–1.90; adjusted OR = 1.20; 95% CI = 0.81–1.77], but the risk was statistically significant among men (adjusted OR = 1.55, 95% CI = 1.00–2.42), current alcohol users (adjusted OR = 1.68, 95% CI = 1.01–2.82), and patients with oral cavity cancer (adjusted OR = 1.77, 95% CI = 1.03–3.04). The p27 109GG variant was also associated with oral tumor overall stage, suggesting that it may play a role in tumor progression.
Conclusions: Our findings suggest that the p27 109GG variant genotype may not play a major role in the etiology of SCCHN but may be associated with an increased risk in at-risk subgroups or subsets of SCCHN, particularly oral cavity cancer and possibly tumor progression. Larger studies with oral squamous cell carcinoma are needed to verify these findings.
This article has been cited by other articles:
|
|
 |
|
  X. Zhai, H. Zhao, Z. Liu, L.-E Wang, A. K. El-Naggar, E. M. Sturgis, and Q. Wei Functional Variants of the NEIL1 and NEIL2 Genes and Risk and Progression of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Clin. Cancer Res., July 1, 2008; 14(13): 4345 - 4352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chen, Z. Hu, L.-E Wang, W. Zhang, A. K. El-Naggar, E. M. Sturgis, and Q. Wei Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., July 15, 2007; 13(14): 4300 - 4305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ozawa, S. K. Agarwal, C. M. Mateo, A. L. Burns, T. S. Rice, P. A. Kennedy, C. M. Quigley, W. F. Simonds, L. S. Weinstein, S. C. Chandrasekharappa, et al. The Parathyroid/Pituitary Variant of Multiple Endocrine Neoplasia Type 1 Usually Has Causes Other than p27Kip1 Mutations J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1948 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, W. K. Hong, C. I. Amos, M. R. Spitz, and Q. Wei Polymorphisms of FAS and FAS Ligand Genes Involved in the Death Pathway and Risk and Progression of Squamous Cell Carcinoma of the Head and Neck. Clin. Cancer Res., September 15, 2006; 12(18): 5596 - 5602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, Z. Liu, E. M. Sturgis, Q. Shi, R. M. Chamberlain, M. R. Spitz, and Q. Wei Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2005; 26(9): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
